1. Home
  2. Knowledge Base
  3. targeted-toxins

targeted-toxins

2314 entries

Hypocretin B-saporin lesions of the brainstem increase rem sleep at night.

Blanco-Centurion CA, Salin-Pascual RJ, Gerashchenko D, Greco MA, Shiromani PJ (2001) Hypocretin B-saporin lesions of the brainstem increase rem sleep at night. Neuroscience 2001 Abstracts 410.9. Society for Neuroscience, San Diego, CA.

Summary: Loss of hypocretin (Hcrt) neurons has been linked to narcolepsy. These neurons project widely throughout brain, but it is not known which projection to which target site produces what symptom of narcolepsy. We (Molec Brain Res, 88:176-182,2001) showed that Hcrt receptors are present in brainstem areas implicated in REM sleep. Since abnormal REM sleep triggering characterizes narcolepsy, we have used Hcrt-saporin, a toxin that selectively lesions Hcrt receptor bearing cells, to assess the effects of such lesions on sleep. In the present study, Sprague Dawley rats (n=21) were administered (under anesthesia) Hcrt-sap (100ng/1ul, vol=0.5 ul bilaterally) or saline to the locus subcoeruleus (LSC) or the medullary inhibitory area of Magoun and Rhines. Subsequently, continuous sleep recordings were made for 21 days. Sleep records were scored blind. In the medulla, Hcrt-sap (n=5) increased the length of REM sleep bouts (p<0.039), which produced a trend towards an increase in REM sleep at night. There were no significant changes in SWS or W. Lesions of the LSC (n=5) increased total sleep time at night (p<0.03) and produced a trend towards a REM sleep increase. Data from both target sites were combined and the Hcrt-sap lesioned rats (n=10 versus saline=11) had a significant increase in REM sleep (30%; p<0.015). At neither site, cataplectic attacks were evident. Our studies with Hcrt-sap indicate site-specific effects on sleep and EEG depending on which Hcrt-receptor bearing neurons are lesioned. All of the symptoms of narcolepsy are evident when the Hcrt-containing neurons are lost. Supported by: NS30140, AG09975, AG15853, MH55772, DVA Med Research.

Related Products: Orexin-B-SAP (Cat. #IT-20)

ATS Poster of the Year Winner. Read the featured article in Targeting Trends.

Cholinergic lesions of the thalamic reticular nucleus using 192-IgG-saporin.

Tait DS, Latimer M, Woodson W, Brown VJ (2001) Cholinergic lesions of the thalamic reticular nucleus using 192-IgG-saporin. Neuroscience 2001 Abstracts 313.13. Society for Neuroscience, San Diego, CA.

Summary: The TRN is likely to be involved in attention, based on studies of its anatomy, electrophysiological properties and the effects of lesions (see Guillery et al, 1998, TINS 21:28-32). The cholinergic neurons of the basal forebrain (BF) have also been implicated in attention (Sarter and Bruno, 2000, Neuroscience, 95:933-952). Intriguingly, rostral TRN receives cholinergic innervation from the BF (Hallanger et al, 1987, J Comp Neurol, 262:105-124) and yet the role of acetylcholine in the TRN has not been investigated, in part because of difficulty in selectively manipulating the cholineric input to TRN. 192-IgG-saporin is a conjugation of the ribosome-inactivating protein, saporin, with the monoclonal antibody for the p75 neurotrophin receptor (192-IgG). 192-IgG-saporin, injected into BF or cortical BF-terminal regions, can be used to make selective cholinergic BF lesions. The purpose of the study was to investigate whether it would be possible to lesion the BF cholinergic input to TRN, using the immunotoxin 192-IgG-saporin. Male Lister hooded rats (450-500g) were stereotaxically injected with 192-IgG-saporin into TRN. Doses of 1.4, 1.95 or 2.4μg produced lesions of TRN, with a loss of cholinergic cells observed in the BF at all doses. There was also evidence of depletion of cholinergic input to frontal cortex with all doses. At the highest dose, there was cholinergic depletion in hippocampus. These results suggest that 192-IgG-saporin can be used to lesion the TRN. The behavioural effects of these lesions are under investigation.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Intrathecal infusion of substance P-saporin ablates substance p receptor expressing neurons in the dorsal horn of the spinal cord and attenuates bone cancer pain.

Luger NM, Sabino MC, Schwei MJ, Rogers SD, Pomonis JD, Keyser CP, Mach DB, Salak-Johnson J, Clohisy DR, Mantyh PW (2001) Intrathecal infusion of substance P-saporin ablates substance p receptor expressing neurons in the dorsal horn of the spinal cord and attenuates bone cancer pain. Neuroscience 2001 Abstracts 55.4. Society for Neuroscience, San Diego, CA.

Summary: Over 75% of advanced cancer patients must cope with chronic cancer pain. Interestingly, bone cancer pain is the most common and difficult to control. While current therapies are effective in alleviating many aspects of bone cancer pain, they are often accompanied by significant unwanted side effects. To better understand the population of spinal cord neurons that are involved in conveying bone cancer pain and to determine the efficacy of a novel therapeutic modality, we ablated substance P receptor (SPR)+ neurons in the spinal cord using intrathecal infusion of substance P-Saporin (SP-SAP). SP-SAP is a suicide ligand which consists of the ribosomal inactivating factor saporin conjugated to substance P, a peptidergic neurotransmitter involved in nociception. SP-SAP selectively ablates SPR+ neurons located in lamina I and III-V of the spinal cord. C3H male mice received intrathecal SP-SAP treatment 30 days prior to injection of 2472 osteosarcoma cells into the intramedulary space of a femur. Following injection, osteolytic sarcoma cells were confined within the femur by an amalgam plug. Mice were behaviorally tested 17 days post-tumor implantation and both ongoing and movement-evoked pain assessed. Ablation of SPR+ neurons in the dorsal spinal cord coincided with attenuation of both spontaneous and movement-evoked pain behaviors. These results suggest that SPR expressing neurons are involved in the development and progression of the bone cancer pain state and SP-SAP may serve as a useful therapy to treat this debilitating condition. Supported by NIH & VA.

Related Products: SP-SAP (Cat. #IT-07)

NK1-expressing neurons critical for morphine reward behaviors in mice: C-fos expression and ablation of NK1-expressing neurons.

Gadd CA, Murtra P, Hall CN, Gana M, Webber MJ, De Felipe C, Hunt SP (2001) NK1-expressing neurons critical for morphine reward behaviors in mice: C-fos expression and ablation of NK1-expressing neurons. Neuroscience 2001 Abstracts 224.13. Society for Neuroscience, San Diego, CA.

Summary: We have previously shown using conditioned place preference (CPP) that mice lacking the preferred receptor for substance P (NK1) show an absence of the rewarding response to morphine as well as reduced conditioned place aversion and physical withdrawal signs following chronic opiate treatment (Nature 405, 180-183). To locate those regions of the brain in which NK1-expressing neurons are crucial for opiate-mediated reward behavior, we examined the expression of c-Fos following acute (10 mg/kg IP) and chronic (increasing doses from 10 to 100 mg/kg IP) morphine administration, and following CPP to morphine (7.5 mg/kg) in wild-type and NK1 knockout mice. The expression of c-Fos in the brains of mice treated with chronic or acute morphine treatment was similar in both genotypes. Moreover, NK1-expressing neurons in the striatum and nucleus accumbens (NAc) were never seen to co-express c-Fos immunoreactivity. In contrast, the expression of c-Fos following the CPP protocol was significantly different between genotypes with a reduced number of c-Fos positive neurons in NK1 knockout mice in the amygdala and hippocampus but not in the NAc or dorsomedial striatum (DMS). We next investigated the effects of selective ablation of NK1 expressing neurons by injecting substance P-saporin into these regions. Our results suggest that destruction of these cells in the amygdala but not in the NAc or DMS causes a reduction in CPP to morphine without affecting anxiety levels or locomotor activity.

Related Products: SP-SAP (Cat. #IT-07)

Nestin expression in neurons of the medial septum/diagonal band in the adult rat.

Yan J, Price DL, Koliatsos VE (2001) Nestin expression in neurons of the medial septum/diagonal band in the adult rat. Neuroscience 2001 Abstracts 25.9. Society for Neuroscience, San Diego, CA.

Summary: Nestin is a marker for neuronal precursor cells in normal animals. In adult animals, nestin (+) cells are limited to the ventricular wall, hippocampus and the rostral migratory stream, where neurogenesis is known to persist throughout life. We are now reporting the existence of nestin (+) cells in the medial septum/diagonal band area based on immunocytochemical staining with different nestin antibodies. Many of these cells colocalize ChAT and nestin. In addition, some nestin (+) cells can be traced with the carbocyanin dye SP-DiI injected into the lateral ventricle to label cell lineages originating in the ependymal layer. Medial septal/diagonal band lesions by complete fimbria-fornix transections or 192-IgG-saporin conjugate injections into the ventricle cause an increase in BrdU (+) and nestin (+) cells in medial septum/diagonal band especially in anterior planes. We are currently double labeling the sections with BrdU and nestin or TUJ1. Our working hypothesis is that there may be ongoing neurogenesis in the medial septum/diagonal band in the adult brain, especially after injury or under pathological conditions and this may have implications for pathogenesis and treatment of Alzheimer’s disease.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Capsaicin-sensitive inhibitory pathway in rat spinal cord dorsal horn.

Gu JG, Nakatsuka T, Tanaka E, Takeda D, Jennifer LX (2001) Capsaicin-sensitive inhibitory pathway in rat spinal cord dorsal horn. Neuroscience 2001 Abstracts 158.13. Society for Neuroscience, San Diego, CA.

Summary: The inhibitory system in the spinal cord plays an important role in regulating nociceptive sensory inputs. Here we examined inhibitory synaptic activity in lamina V neurons of the spinal dorsal horn following the activation of capsaicin VR1 receptors. Experiments were performed with spinal cord slice preparations and inhibitory postsynaptic currents (IPSCs) were recorded using patch-clamp technique. Bath application of capsaicin (2 μM) increased the amplitude and frequency of GABAergic and glycinergic spontaneous IPSCs in the majority of lamina V neurons tested. The effects of capsaicin were completely antagonized by capsazepine (10 μM), and were also blocked in the presence of tetrodotoxin (0.5 μM). However, when CNQX (20 μM) and APV (100 μM) were used to block glutamatergic synaptic transmission, the effects of capsaicin were not abolished. Furthermore, after the injection of IB4-saporin into sciatic nerve to remove IB4-positive C-primary afferent terminals, capsaicin still increased sIPSC frequency in the presence of CNQX and APV. These results suggest that inhibitory pathway could be recruited in the absence of glutamatergic inputs from primary afferents. The release of neuropeptides from capsaicin-sensitive C-primary afferents may activate GABAergic and glycinergic interneurons in superficial laminae, and the inhibitory activity may be further forwarded to lamina V neurons. The capsaicin-sensitive inhibitory pathway may play an important role in the control of nociceptive transmission in the spinal cord.

Related Products: IB4-SAP (Cat. #IT-10)

Memory enhancement induced by post-training norepinephrine in the basolateral amygdala is blocked by 192-IgG saporin lesions of the nucleus basalis magnocellularis.

Power AE, Thal LJ, McGaugh JL (2001) Memory enhancement induced by post-training norepinephrine in the basolateral amygdala is blocked by 192-IgG saporin lesions of the nucleus basalis magnocellularis. Neuroscience 2001 Abstracts 84.13. Society for Neuroscience, San Diego, CA.

Summary: Drugs and stress hormones act in the basolateral amygdala (BLA) to modulate memory storage. The BLA projects to the nucleus basalis magnocellaris (NBM), which sends broad cholinergic projections to the neocortex. These NBM-cortex projections have been implicated in learning, memory storage and cortical plasticity. The current study was designed to test whether the cholingeric NBM-cortex projections are involved in BLA-mediated memory modulation. Rats were given bilateral cholinergic lesions of the NBM with 192-IgG saporin (0.1 μg/ 0.5 μl per side) or sham infusions, and implanted with bilateral cannulae aimed at the BLA. One week after surgery the rats were trained in the inhibitory avoidance task. Immediately after training, the rats were given bilateral infusions of norepinephrine (0.3μg, 1.0 μg, or 3.0 μg) or vehicle (0.2 μl PBS) into the BLA. On a 48-h retention test, the norepinephrine infusions produced a dose-dependent enhancement of retention (0.3μg and 1.0 μg doses) in sham-operated controls. NBM-lesioned rats that received these memory-enhancing doses of norepinephrine had retention latencies that did not differ from vehicle infused controls. Thus memory enhancement induced by post-training intra-BLA infusion of norepinephrine was blocked in 192-IgG saporin NBM-lesioned rats. ChAT assays of frontal and occipital cortices confirmed the lesions. These findings indicate that the cholinergic NBM-cortex projections are involved in BLA-mediated modulation of memory.

Related Products: 192-IgG-SAP (Cat. #IT-01)

α,β-methylene ATP sensitive P2X receptor mediated enhancement of glutamate release from the central terminals of Aδ primary afferents onto lamina V neurons in rat spinal cord.

Nakatsuka T, Takeda D, Gu JG (2001) α,β-methylene ATP sensitive P2X receptor mediated enhancement of glutamate release from the central terminals of Aδ primary afferents onto lamina V neurons in rat spinal cord. Neuroscience 2001 Abstracts 158.16. Society for Neuroscience, San Diego, CA.

Summary: We examined the role of αβmATP-sensitive P2X receptors in modulating glutamate release from sensory synapses of the spinal cord by using whole-cell patch-clamp recordings from dorsal horn neurons in lamina V region. The majority of lamina V neurons synapsed with terminals expressing αβmATP-sensitive P2X receptors. Application of P2X receptor agonist 100 μM αβmATP resulted in a large increase in mEPSC frequency. The increases in mEPSC frequency by αβmATP were completely abolished by the P2X receptor antagonist 10 μM PPADS, but were not blocked by Ca2+ channel blocker 30 μM La3+. αβmATP remained to be effective in increasing mEPSC frequency after the removal of superficial dorsal horn (lamina I-III) or after the injection of IB4-saporin into sciatic nerve to remove P2X3 expressing afferent terminals. Furthermore, we found that αβmATP-sensitive synapses of lamina V neurons were associated with central terminals derived from Aδ primary afferents. The EPSCs evoked by dorsal root stimulation at Aδ-fiber intensity were potentiated by 1 μM αβmATP as well as by the ecto-ATPase inhibitor 10 μM ARL67156, and depressed in the presence of 10 μM PPADS and 5 μM suramin. These results suggest that αβmATP-sensitive P2X receptors play a significant role in modulating excitatory synaptic transmission in the spinal cord.

Related Products: IB4-SAP (Cat. #IT-10)

The effects of 192 IgG-saporin lesions to the nucleus basalis magnocellularis/substantia innominata (nBM/SI) on two learning set formation tasks and open field activity.

Bailey AM, Rudisill ML, Hoof EM, Loving ML (2001) The effects of 192 IgG-saporin lesions to the nucleus basalis magnocellularis/substantia innominata (nBM/SI) on two learning set formation tasks and open field activity. Neuroscience 2001 Abstracts 85.13. Society for Neuroscience, San Diego, CA.

Summary: Male Long Evans rats (Rattus norvegicus) were used to investigate the role of the nucleus basalis magnocellularis/substantia innominata (nBM/SI) in learning set formation. Rats with bilateral 192 IgG-Saporin lesions to the nBM/SI were tested on olfactory discrimination learning set, discrimination reversal learning set, and open field activity. Assessment of open field activity indicated no group differences in general activity levels. Control animals performed significantly better than chance on trial 2 across the 50 problems given in the olfactory discrimination learning set paradigm, suggesting evidence of learning set formation. The nBM/SI lesion group did not perform significantly above chance on trial 2 overall; however, they did perform above chance on trial 2 over the last 10 problems in the olfactory discrimination learning set task. Discrimination reversal followed testing on the olfactory discrimination learning set task. No group differences were seen in discrimination reversal performance. Both control and nBM/SI lesioned animals performed well on the discrimination reversal learning set task, improving with each reversal, and both groups performed significantly higher than expected by chance on trial 2 in the discrimination reversal paradigm, indicating learning set formation. Results suggest that removal of the nBM/SI cholinergic system through 192 IgG-Saporin lesions impairs early acquisition of learning set compared to control animals, but does not interrupt later use of learning set formation.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Cyclosporine-A improves performance in passive avoidance task in adult rats with basal forebrain lesions.

Stahl CE, Kusayama T, Keep M, Elmer E, Watanabe S, Borlongan CV (2001) Cyclosporine-A improves performance in passive avoidance task in adult rats with basal forebrain lesions. Neuroscience 2001 Abstracts 101.11. Society for Neuroscience, San Diego, CA.

Summary: While mainly used as an immunosuppressant, newly identified properties of CsA suggest its potential as a therapeutic agent for neurological disorders. In the present study, we investigated the effects of CsA in acquisition and retention of passive avoidance task in adult rats lesioned with 192-IgG-saporin, an immunotoxin that targets cholinergic neurons in the basal forebrain. Starting on the day of the lesion up to 7 days thereafter, animals received either daily CsA (10 mg/kg, i.p. ) or vehicle alone. On day 8 (acquisition), animals were trained in a three-compartment shuttle box passive avoidance task. Twenty-fours later, the retention tests were performed. During the acquisition phase, animals that received CsA treatment significantly entered less in the shock-associated box than those that received vehicle alone. However, the mean total acquisition times between the two groups were not statistically significant. In the retention phase, CsA-treated animals displayed significantly longer latency to stay in the safe compartment compared to vehicle-treated animals. Histological analysis using ChAT immunostaining revealed sparing (80% of control) of basal forebrain cholinergic neurons in CsA-treated animals. The use of CsA may prove beneficial for treatment of neurological disorders characterized by a dysfunctional cholinergic system.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Shopping Cart
Scroll to Top